Guo, Guangxin
Xu, Xiruo
Yin, Wong Yu
Zhang, Kunyu
Hui, Jacelyn Pang Min
Yee, Janice Hiew Yuen
Heng, Bryan Chung Qi
Qin, Yuan
Yao, Fei
Fang, Min
Funding for this research was provided by:
Future Plan for Traditional Chinese Medicine Inheritance and Development of Shanghai Municipal Hospital of Traditional Chinese Medicine (WLJH2021ZY-GZS007)
Shanghai Post-doctoral Excellence Program (2020371)
Postdoctoral Research Foundation of China (2021M692156)
Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202008)
Article History
Received: 5 May 2022
Accepted: 5 October 2022
First Online: 14 October 2022
Declarations
:
: Ethical approval was requested and granted by the Ethics Committee of Shanghai Hudong hospital (item number: 2021-SHHUKY03). If necessary, researchers can submit a request to modify the protocol, for example, the primary outcome and sample size calculation. The steering committee and ethics committee have the authority to allow the modification of the plan. All participants will provide informed consent before starting any data collection. Informed consent will be collected by the principal investigators (LF). And only the investigators have access to the final data. The protocol was registered in the Chinese Clinical Trials Registry on 03 May 2022 under the accession number ChiCTR2200059504.
: This section is “not applicable” as no personal information is provided in this manuscript.
: The authors declare that they have no competing interests.